Menu Back toArtificial Intelligence: Real Applications and Regulatory Perspectives

DIA 2021 Global Annual Meeting

Artificial Intelligence: Real Applications and Regulatory Perspectives

Session Chair(s)

Jeremy Jokinen, PhD, MS

Jeremy Jokinen, PhD, MS

  • Vice President, Epidemiology, Safety Science, Capabilities and Innovation
  • Bristol-Myers Squibb Company, United States
Artificial Intelligence (AI) remains a commonly used phrase with few examples of use within the pharmaceutical industry. In this session, speakers will share their experience with artificial intelligence applications across the healthcare industry. Speakers will discuss real-world applications of artificial intelligence and near-term opportunities currently being pursued by pharmaceutical and technology companies and healthcare systems. Additionally, this session will cover the perspective of regulators to this rapidly changing field. Speakers will share their perspectives regarding the future of these technologies to influence patient safety and healthcare broadly. Join the Clinical Safety & Pharmacovigilance Community for a follow up round table discussion (session #330.2 RT L) on Wednesday, June 30, 12:00PM - 1:00PM EDT.
Learning Objective : Describe current applications of AI within pharmaceutical, technology, and healthcare settings; Discuss evolving regulation and regulatory perspective; Identify the barriers to implementation of AI in healthcare; Assess the promise and pitfalls of these advanced technologies.

Speaker(s)

Tom Sabo, MS

Developing a Deep Learning MedDRA Encoder (MedDRA-DeepCoder) for Patient Narratives

Tom Sabo, MS

  • Principal Solutions Architect
  • SAS Institute Inc., United States
Qais Hatim, PhD

Deep Learning at the FDA

Qais Hatim, PhD

  • Data Scientist, OTS, CDER
  • FDA, United States
Bakul Patel, MBA, MS

Tailoring FDA's Regulatory Framework to Encourage Responsible Innovation in Artificial Intelligence and Machine Learning

Bakul Patel, MBA, MS

  • Director, Digital Health Center of Excellence (DHCoE), CDRH
  • FDA, United States
Sameen Desai, MBA, MS

Image Fingerprinting as a Means for Individual Case Safety Report Classification: A Convolutional Neural Network

Sameen Desai, MBA, MS

  • Senior Director, Head Digital Insights and Innovation
  • Bristol-Myers Squibb Company, United States
Raj Ratwani, PhD

Human Factors and Responsible Use of Artificial Intelligence

Raj Ratwani, PhD

  • Vice President of Scientific Affairs
  • MedStar Health Research Institute, United States